Abstract
Cardiac hypertrophy can be divided as pathological hypertrophy and physiological hypertrophy. Unlike pathological hypertrophy, physiological hypertrophy is a beneficial adaptive response, which will not cause heart failure and sudden death and can protect adverse cardiac remodeling. Exercise training is widely known to cause physiological hypertrophy. The genomic basis of pathological hypertrophy and heart failure has been well-known and is well-reviewed. In this review, we will review the genomic profiles of physiological hypertrophy and also summarize genes and microRNAs responsible for exercise-induced physiological hypertrophy. With better understanding of physiological hypertrophy, manipulation of genes or miRNAs responsible for physiological hypertrophy will offer exciting avenues for treating heart failure.
Keywords: Exercise, Physiological hypertrophy, Genomics, MicroRNA
Graphical Abstract
Current Genomics
Title:Exercise-induced Physiological Hypertrophy: Insights from Genomics
Volume: 16 Issue: 2
Author(s): Dongchao Lv, Qi Sun, Yuping Deng, Jiahong Xu, Huansen Huang and Junjie Xiao
Affiliation:
Keywords: Exercise, Physiological hypertrophy, Genomics, MicroRNA
Abstract: Cardiac hypertrophy can be divided as pathological hypertrophy and physiological hypertrophy. Unlike pathological hypertrophy, physiological hypertrophy is a beneficial adaptive response, which will not cause heart failure and sudden death and can protect adverse cardiac remodeling. Exercise training is widely known to cause physiological hypertrophy. The genomic basis of pathological hypertrophy and heart failure has been well-known and is well-reviewed. In this review, we will review the genomic profiles of physiological hypertrophy and also summarize genes and microRNAs responsible for exercise-induced physiological hypertrophy. With better understanding of physiological hypertrophy, manipulation of genes or miRNAs responsible for physiological hypertrophy will offer exciting avenues for treating heart failure.
Export Options
About this article
Cite this article as:
Lv Dongchao, Sun Qi, Deng Yuping, Xu Jiahong, Huang Huansen and Xiao Junjie, Exercise-induced Physiological Hypertrophy: Insights from Genomics, Current Genomics 2015; 16 (2) . https://dx.doi.org/10.2174/1389202916999150120153618
DOI https://dx.doi.org/10.2174/1389202916999150120153618 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Loop Diuretics Strategies in Acute Heart Failure: From Clinical Trials to Practical Application
Current Drug Targets Cell Death and Apoptosis in Ostearthritic Cartilage
Current Drug Targets Exercise-Induced Overexpression of Angiogenic Factors and Reduction of Ischemia / Reperfusion Injury in Stroke
Current Neurovascular Research Association of Common Variants in the IL-33/ST2 Axis with Ischemic Stroke
Current Neurovascular Research Meet Our Co-Editor
Current Vascular Pharmacology Immunosuppressive Therapies in Solid Organ Transplantation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Nanomedicine for Gene Delivery for the Treatment of Cardiovascular Diseases
Current Gene Therapy Recent Progress in the Development of Quinoline Derivatives for the Exploitation of Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Application of Erythropoietin in Chronic Heart Failure Treatment
Mini-Reviews in Medicinal Chemistry Unconventional Players on the Striated Muscle Field: microRNAs, Signaling Pathways and Epigenetic Regulators
Current Stem Cell Research & Therapy Recent advances in the management of autoimmune myocarditis: insights from animal studies.
Current Pharmaceutical Design Retroviral Vector-mediated Gene Therapy for Metabolic Diseases: An Update
Current Pharmaceutical Design A Review on Recent Patents in Digital Processing for Cardiac Electric Signals (I): From Basic Systems to Arrhythmia Analysis
Recent Patents on Biomedical Engineering (Discontinued) The Relaxin Peptide Family – Structure, Function and Clinical Applications
Protein & Peptide Letters Blood Pressure and the Risk of Dementia: A Dose-Response Meta-Analysis of Prospective Studies
Current Neurovascular Research Hemodynamic Regulation of Metallopeptidases within the Vasculature
Protein & Peptide Letters New Therapies to Modulate Post-Infarction Inflammatory Alterations in the Myocardium: State of the Art and Forthcoming Applications
Current Radiopharmaceuticals Heart Failure and Diabetes: Perspective of a Dangerous Association
Current Hypertension Reviews Heart Failure in Diabetes Mellitus: An Updated Review
Current Pharmaceutical Design Thrombolytic Therapy in Acute Ischemic Stroke - Basic Concepts
Current Vascular Pharmacology